Cymat Technologies Current Debt
CYMHF Stock | USD 0.13 0.02 13.33% |
Cymat Technologies holds a debt-to-equity ratio of 0.878. Cymat Technologies' financial risk is the risk to Cymat Technologies stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Cymat Technologies' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Cymat Technologies' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Cymat OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Cymat Technologies' stakeholders.
For most companies, including Cymat Technologies, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Cymat Technologies, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Cymat Technologies' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Cymat Technologies' debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Cymat Technologies is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Cymat Technologies to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Cymat Technologies is said to be less leveraged. If creditors hold a majority of Cymat Technologies' assets, the OTC Stock is said to be highly leveraged.
Cymat |
Cymat Technologies Debt to Cash Allocation
Many companies such as Cymat Technologies, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Cymat Technologies has accumulated 123.93 K in total debt with debt to equity ratio (D/E) of 0.88, which is about average as compared to similar companies. Cymat Technologies has a current ratio of 2.15, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Cymat Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Cymat Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cymat Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cymat to invest in growth at high rates of return. When we think about Cymat Technologies' use of debt, we should always consider it together with cash and equity.Cymat Technologies Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Cymat Technologies' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Cymat Technologies, which in turn will lower the firm's financial flexibility.Understaning Cymat Technologies Use of Financial Leverage
Cymat Technologies' financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Cymat Technologies' total debt position, including all outstanding debt obligations, and compares it with Cymat Technologies' equity. Financial leverage can amplify the potential profits to Cymat Technologies' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Cymat Technologies is unable to cover its debt costs.
Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company was incorporated in 2006 and is based in Mississauga, Canada. Cymat Technologies is traded on OTC Exchange in the United States. Please read more on our technical analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cymat OTC Stock
Cymat Technologies financial ratios help investors to determine whether Cymat OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cymat with respect to the benefits of owning Cymat Technologies security.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.